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We report ﬁ  nding Rickettsia parkeri in Brazil in 9.7% 
of Amblyomma triste ticks examined. An R. parkeri isolate 
was successfully established in Vero cell culture. Molecu-
lar characterization of the agent was performed by DNA 
sequencing of portions of the rickettsial genes gltA, htrA, 
ompA, and ompB.
T
he ﬁ  rst reported infection with Rickettsia parkeri was 
in Amblyomma maculatum ticks in Texas >65 years 
ago (1). Although its pathogenicity for humans was sus-
pected or speculated during the following decades (2), R. 
parkeri was only recently recognized as a human tickborne 
pathogen (3). Extensive cross-reactivity exists among spot-
ted fever group rickettsiae—especially R. rickettsii (the 
etiologic agent of Rocky Mountain spotted fever [RMSF] 
and Brazilian spotted fever [BSF])—and R. parkeri. Most 
of the time, R. rickettsii antigen is the only antigen used in 
serologic analysis for routine diagnosis of RMSF and BSF. 
Thus, many human cases of R. parkeri infection may be 
routinely misidentiﬁ  ed as RMSF (2).
During the 1990s in Uruguay, several human cases of a 
tickborne rickettsiosis were diagnosed on the basis of sero-
logic analyses; the spotted fever group organism R. conorii 
was used as antigen (4). Because R. conorii has never been 
found in the Western Hemisphere, another spotted fever 
group rickettsia may have been responsible for the reported 
cases (5). Because of recent reports of R. parkeri infection 
among A. triste ticks in Uruguay (where A. triste is the 
most common human-biting tick), this rickettsia has been 
suggested as the most probable agent of the Uruguayan 
spotted fever rickettsiosis (5,6). These data are corroborat-
ed by similar clinical ﬁ  ndings found for both the American 
spotted fever caused by R. parkeri and Uruguayan spotted 
fever (2,4). R. parkeri has been reported only in the United 
States and Uruguay. We report R. parkeri infection of A. 
triste ticks in Brazil.
The Study
A. triste ticks were collected in a marsh area 
(21°07′06.7′′S, 51°46′06.5′′W) in Paulicéia County, state 
of São Paulo, Brazil. This area harbors a natural population 
of A. triste, mostly in the natural marsh environment along 
the Paraná River (7). Marsh deer (Blastocerus dichotomus) 
have been implicated as primary hosts for the adult stage of 
A. triste in the area, but the hosts for the immature stages of 
the tick remain unknown (7).
In January 2005, free-living adult A. triste ticks were 
collected by use of dry ice traps. Collected ticks were taken 
alive to the laboratory, where they were screened for rick-
ettsial infection by using the hemolymph test with Gimenez 
staining (8). Immediately after hemolymph was collected, 
the ticks were stored at –80°C until used for further testing.
Ticks with hemolymph test results positive for infec-
tion with a Rickettsia-like organism were processed for 
isolation of Rickettsia in cell culture by using the shell vial 
technique (9). In brief, Vero cells were inoculated with tick 
body homogenate and incubated at 28°C. The level of cell 
infection was monitored by Gimenez staining of scraped 
cells from the inoculated monolayer; a rickettsial isolate 
was considered established after 3 passages, each reaching 
>90% of infected cells (9).
For cell isolation, a sample of 100%-infected cells 
from the fourth Vero cell passage was subjected to DNA 
extraction and thereafter tested by a battery of PCRs by 
using previously described primer pairs that targeted frag-
ments of the rickettsial genes gltA, htrA, ompA, and ompB 
(10). Ampliﬁ  ed products were puriﬁ  ed and sequenced (9) 
and then compared with National Center for Biotechnology 
Information (NCBI) nucleotide BLAST searches (www.
ncbi.nlm.nih.gov/blast).
Tick specimens with hemolymph test results negative 
for Rickettsia-like were thawed and individually processed 
for DNA extraction by the guanidine isothiocyanate–phe-
nol technique (11). PCR ampliﬁ  cation of a rickettsial gene 
fragment (398 nt) of the citrate synthase gene (gltA) was 
attempted on DNA from each tick by using the primers CS-
78 and CS-323, which were designed to amplify DNA from 
all known Rickettsia spp. (9). Tick samples shown by PCR 
to be positive were tested further by a second PCR, which 
used the primers Rr190.70p and Rr190.602n, which am-
plify a 530-nt fragment of most of the spotted fever group 
Rickettsia (12). PCR products of the expected sizes were 
puriﬁ  ed and sequenced (9) and then compared with NCBI 
nucleotide BLAST searches.
A total of 31 adult specimens of A. triste ticks were 
collected in January 2005. Specimens from 3 of the 31 
ticks contained Rickettsia-like organisms, as determined 
by the hemolymph test. PCR ampliﬁ  cation of the remain-
ing 28 tick specimens was negative for Rickettsia spp. A 
Rickettsia organism was successfully isolated from only 1 
of the 3 ticks with positive hemolymph test results. The 
isolate, designated as At24, was successfully established in 
Vero cell culture. PCR performed on DNA extracted from 
infected cells yielded the expected PCR products for all re-
actions. After DNA sequencing, the generated sequences 
of 1093, 489, 479, and 775 nt for the gltA, htrA, ompA, 
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and  ompB genes, respectively, showed 100%, 99.8%, 
100%, and 100% identity to corresponding sequences of R. 
parkeri Maculatum strain from the United States (GenBank 
accession nos. U59732, U17008, U43802, AF123717, re-
spectively). Isolation attempts for the other 2 ticks with 
positive hemolymph test results were lost because of bac-
terial or fungal contamination. Nevertheless, remnants of 
ticks used to inoculate Vero cells were subjected to DNA 
extraction and tested by PCR for the gltA and ompA genes, 
as described above for ticks. Expected products were ob-
tained from these PCR studies, and the generated sequenc-
es were 100% identical to the corresponding sequences 
of R. parkeri Maculatum strain (GenBank accession nos. 
U59732 and U43802, respectively). The frequency of R. 
parkeri infection among ticks examined in this study was 
9.7% (3/31). Partial sequences (gltA, htrA, ompA, ompB) 
from R. parkeri strain At24 generated in this study were 
deposited into GenBank and assigned nucleotide accession 
nos. EF102236–EF102239, respectively.
Conclusions
Our report of R. parkeri infection of ≈10% of A. triste 
ticks from 1 area in the state of São Paulo highlights the 
possibility of R. parkeri causing human cases of spotted 
fever rickettsiosis in Brazil. However, in contrast to Uru-
guay, Brazil appears to have rare occurrences of A. triste 
and has never had a report of an A. triste bite in humans. In 
addition, no human case of spotted fever has been reported 
from sites within the known distribution area of A. triste in 
Brazil. On the other hand, an R. parkeri–like agent (strain 
Cooperi) was recently reported to have infected A. dubita-
tum ticks from a BSF-endemic area in São Paulo (9). Since 
A. dubitatum is a human-biting tick that is highly prevalent 
in many BSF-endemic areas (13), it is a potential candidate 
for transmission of R. parkeri to humans.
Spotted fevers caused by R. parkeri and by R. rick-
ettsii differ in 2 ways: an eschar frequently occurs at the 
tick bite site in spotted fever cases caused by R. parkeri, 
and lymphadenopathy occurs in cases caused by R. parkeri. 
Because clinical descriptions of BSF (diagnosed solely by 
serologic testing that uses R. rickettsii antigen) with these 
speciﬁ  c clinical signs have been described recently in Bra-
zil (14,15), human infections with R. parkeri may be occur-
ring in this country. These clinical descriptions were from 
areas with large populations of A. dubitatum but no known 
occurrence of A. triste. Moreover, because R. rickettsii an-
tigen has been the only antigen regularly used for diagno-
sis of BSF, human spotted fever cases due to R. parkeri or 
other spotted fever group rickettsiae may be misidentiﬁ  ed 
as BSF in Brazil.
Our study demonstrated an exact concordance between 
ticks that were positive for Rickettsia-like organisms by the 
hemolymph test and those that were positive for rickettsial 
DNA by PCR. Previous studies in our laboratory (9–11) 
have demonstrated the same results or a slightly higher sen-
sitivity of PCR for detection of rickettsiae in ticks.
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